Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-25-000145
Filing Date
2025-01-17
Accepted
2025-01-17 07:09:46
Documents
3
Period of Report
2025-01-17

Document Format Files

Seq Description Document Type Size
1 6-K zk2532569.htm 6-K 8414
2 BIOLINERX ANNOUNCES CHANGE TO RATIO OF AMERICAN DEPOSITARY SHARES TO ORDINARY SH exhibit_1.htm EX-99 14641
3 image0.jpg GRAPHIC 27798
  Complete submission text file 0001178913-25-000145.txt   62630
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 25536999
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)